Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1617.99%
operating margin TTM
-1425.33%
revenue TTM
9.49 Million
revenue per share TTM
0.07$
valuation ratios | |
|---|---|
| pe ratio | -14.69 |
| peg ratio | 6.57 |
| price to book ratio | 11.82 |
| price to sales ratio | 238.06 |
| enterprise value multiple | -15.42 |
| price fair value | 11.82 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -1425.33% |
| pretax profit margin | -1595.38% |
| net profit margin | -1617.99% |
| return on assets | -54.14% |
| return on equity | -67.68% |
| return on capital employed | -51.0% |
liquidity ratios | |
|---|---|
| current ratio | 10.57 |
| quick ratio | 10.57 |
| cash ratio | 1.74 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 1,270.52 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 1,270.52 |
| receivables turnover | 0.29 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.26 |
| debt equity ratio | 0.39 |
| long term debt to capitalization | 0.27 |
| total debt to capitalization | 0.28 |
| interest coverage | -19.21 |
| cash flow to debt ratio | -1.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.35 |
| cash per share | 1.84 |
| operating cash flow per share | -1.35 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.53 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -502.25 |
Frequently Asked Questions
When was the last time Centessa Pharmaceuticals plc (NASDAQ:CNTA) reported earnings?
Centessa Pharmaceuticals plc (CNTA) published its most recent earnings results on 05-11-2025.
What is Centessa Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Centessa Pharmaceuticals plc (NASDAQ:CNTA)'s trailing twelve months ROE is -67.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Centessa Pharmaceuticals plc (CNTA) currently has a ROA of -54.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CNTA's net profit margin stand at?
CNTA reported a profit margin of -1617.99% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CNTA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.57 in the most recent quarter. The quick ratio stood at 10.57, with a Debt/Eq ratio of 0.39.